176 related articles for article (PubMed ID: 15678682)
1. [Monoclonal antibody-based design of antitumor drugs: prerequisites and progress].
Chmutin EF; Ivanov PK; Baryshnikov AIu
Vestn Ross Akad Med Nauk; 2004; (12):10-6. PubMed ID: 15678682
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic monoclonal antibodies in onco-hematology].
Cartron G; Rossi JF
Med Sci (Paris); 2009 Dec; 25(12):1085-9. PubMed ID: 20035683
[TBL] [Abstract][Full Text] [Related]
3. [Anti-cancer monoclonal antibody].
Sasaki S; Ishida T; Tsujisaki M; Imai K
Nihon Rinsho; 2005 Apr; 63 Suppl 4():608-12. PubMed ID: 15861718
[No Abstract] [Full Text] [Related]
4. Monoclonal antibodies as therapeutic agents for cancer.
Harris M
Lancet Oncol; 2004 May; 5(5):292-302. PubMed ID: 15120666
[TBL] [Abstract][Full Text] [Related]
5. The rollercoaster ride to anti-cancer antibodies.
Weiner LM; Carter P
Nat Biotechnol; 2003 May; 21(5):510-1. PubMed ID: 12721576
[No Abstract] [Full Text] [Related]
6. Binding of rituximab, trastuzumab, cetuximab, or mAb T101 to cancer cells promotes trogocytosis mediated by THP-1 cells and monocytes.
Beum PV; Mack DA; Pawluczkowycz AW; Lindorfer MA; Taylor RP
J Immunol; 2008 Dec; 181(11):8120-32. PubMed ID: 19018005
[TBL] [Abstract][Full Text] [Related]
7. Immunotoxin therapy of malignancy.
Grossbard ML; Nadler LM
Important Adv Oncol; 1992; ():111-35. PubMed ID: 1582669
[No Abstract] [Full Text] [Related]
8. Atemonate and Imuteran: novel Russian monoclonal antibody-based therapeutic agents.
Ivanov PK; Blokhin DY; Chmutin EF; Grinevich AS; Perlin DV; Sokolsky AS; Yakubovskaya RI; Baryshnikov AY
Biotechnol J; 2007 Jul; 2(7):863-70. PubMed ID: 17526052
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies in cancer therapy: 25 years of progress.
Oldham RK; Dillman RO
J Clin Oncol; 2008 Apr; 26(11):1774-7. PubMed ID: 18398141
[No Abstract] [Full Text] [Related]
10. AntiCD20 mAbs: modifying therapeutic strategies and outcomes in the treatment of lymphoma patients.
Grillo-López AJ
Expert Rev Anticancer Ther; 2002 Jun; 2(3):323-9. PubMed ID: 12113055
[TBL] [Abstract][Full Text] [Related]
11. Improving the efficacy of antibody-based cancer therapies.
Carter P
Nat Rev Cancer; 2001 Nov; 1(2):118-29. PubMed ID: 11905803
[TBL] [Abstract][Full Text] [Related]
12. A rapid and efficient in vivo method for determining the biologic efficacy of monoclonal antibodies in animal models of cancer.
Staquet K; Giles-Komar J
Hybridoma (Larchmt); 2006 Apr; 25(2):68-74. PubMed ID: 16704306
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody therapy.
O'Mahony D; Bishop MR
Front Biosci; 2006 May; 11():1620-35. PubMed ID: 16368542
[TBL] [Abstract][Full Text] [Related]
14. Antibodies in oncology.
Pillay V; Gan HK; Scott AM
N Biotechnol; 2011 Sep; 28(5):518-29. PubMed ID: 21473941
[TBL] [Abstract][Full Text] [Related]
15. Antibody-directed, effector cell-mediated tumor destruction.
Sondel PM; Hank JA
Hematol Oncol Clin North Am; 2001 Aug; 15(4):703-21. PubMed ID: 11676280
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies as targeted therapy in hematologic malignancies in older adults.
Rao AV; Schmader K
Am J Geriatr Pharmacother; 2007 Sep; 5(3):247-62. PubMed ID: 17996665
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic antibodies against cancer.
Adler MJ; Dimitrov DS
Hematol Oncol Clin North Am; 2012 Jun; 26(3):447-81, vii. PubMed ID: 22520975
[TBL] [Abstract][Full Text] [Related]
18. Editorial: what ails solid tumor radioimmunotherapy?
Divgi C
Cancer Biother Radiopharm; 2006 Apr; 21(2):81-4. PubMed ID: 16706627
[No Abstract] [Full Text] [Related]
19. [Development of monoclonal antibody therapy for malignant lymphoma].
Ogura M
Nihon Rinsho; 2002 Mar; 60(3):505-16. PubMed ID: 11904966
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic monoclonal antibodies in oncology.
Levene AP; Singh G; Palmieri C
J R Soc Med; 2005 Apr; 98(4):146-52. PubMed ID: 15805554
[No Abstract] [Full Text] [Related]
[Next] [New Search]
